DUBLIN, March 11, 2019 — The “Global Viral Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering.
Global Viral Partnering 2014 to 2019 provides the full collection of Viral disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Viral disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Viral deals.
The report presents financial deal terms values for Viral deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Viral dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Viral dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Viral deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Viral dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Viral deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all Viral partnering deals by specific Viral target announced since 2014. The chapter is organized by specific Viral therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all Viral partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Viral partnering and dealmaking since 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Viral technologies and products.
Key Topics Covered:
Chapter 1 – Introduction
Chapter 2 – Trends in Viral dealmaking
2.2. Viral partnering over the years
2.3. Viral partnering by deal type
2.4. Viral partnering by industry sector
2.5. Viral partnering by stage of development
2.6. Viral partnering by technology type
2.7. Viral partnering by therapeutic indication
Chapter 3 -Financial deal terms for Viral partnering
3.2. Disclosed financials terms for Viral partnering
3.3. Viral partnering headline values
3.4. Viral deal upfront payments
3.5. Viral deal milestone payments
3.6. Viral royalty rates
Chapter 4 – Leading Viral deals and dealmakers
4.2. Most active in Viral partnering
4.3. List of most active dealmakers in Viral
4.4. Top Viral deals by value
Chapter 5 – Viral contract document directory
5.2. Viral partnering deals where contract document available
Chapter 6 – Viral dealmaking by therapeutic target
6.2. Deals by Viral therapeutic target
Appendix 1 – Directory of Viral deals by company A-Z 2014 to 2019
Appendix 2 – Directory of Viral deals by deal type 2014 to 2019
Appendix 3 – Directory of Viral deals by stage of development 2014 to 2019
Appendix 4 – Directory of Viral deals by technology type 2014 to 2019
For more information about this report visit https://www.researchandmarkets.com/research/swjmbm/global_viral?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets